Cells Are a Type of

cells are a type of white blood cell, called a lymphocyte that is critical to the immune system. Since they are like soldiers that search out and destroy invaders, attempts have been made in recent years to generate mature T-cells, engineer other T-cells and introduce them into the immune system, and manipulate them -- place them precisely in specific positions so that they are best able to recognize and fight antigens -- the invaders (MedecineNet.com).

One way that this is done is through "adoptive T-cell cancer therapy" (see e.g. Greenberg, 1991; June, 2007) which means that mature T-cells are infused into the immune system in order to eliminate a tumor and prevent its recurrence. The advantages with this type of therapy are that T- cells have a long clonal life span (Jamieson & Ahmed, 1989), and are well suited for genetic manipulation.

For adoptive T-cell therapy to best work, one has to be careful to select the best T-cells, to engineer them, and then to encourage them to proliferate whilst keeping their abilities intact. These abilities include 'ferreting out' invaders, attaching themselves to other cells, and working as well as they do in natural conditions. T-cells exist in several stages of growth and category. There are three main categories by which it has been suggested T-cells can be generated: 1.

The linear differentiation model - a conversion from naive (beginning) to effector (a working T-cell) to actual generated T-cell through a process of differentiating and producing one from the other in a linear-type fashion. 2. The signal strength model - Signals of T-cells are strengthened, and when they reach their peak they proliferate and differentiation (growth and separation from 'mother' cell occurs. T-cells receiving weakest signals do not survive; so much depends on the strength and stability of the signal. 3.

The stem cell model - the cells within the T-cell are self-renewing, and they can be used for deriving effecter T-cells (namely T-cells that are able to impact). Since naive T-cells are too weak to kill tumor cells, and since in vivo T-cells are superior to in vitro T-cells, it has been thought that adoptive T-cell transfer strategies are the best way to promote populations of T-cells that will live a long while within the immune system and be strong enough to combat tumor.

To date, adoptive T-cell therapy have used peripheral blood, tumors, malignant effusions, and drained lymph nodes as sites for injecting the T-cells for adoptive transfer. Those are routinely used are allogenic bone marrow transplantation and peripheral blood stem cell infusion. It is possible that the bone marrow might be a good place too. It is also arguable which precise T-cells are the best to transfer, since T- cells are differentiated into many subsets.

Furthermore, in order to produce enough effectors T-cells, specific T-cells from peripheral blood or tumor specimens are isolated and generated in vitro, and these are then clonally expanded using various approaches. The T-cells are then reinfused into the patient with the expectation that they will then target antigens. There is much evidence that this approach works, although it also seems that this can be engineered in vivo under certain situations.

For most effective T-cell therapy, it has been shown that telemores which is the element that is involved in cell proliferation is an important factor. In other words, the larger and stronger the size of the cell and the more 'intense' its memory for proliferation, the more optimal the T-cell is for long-term immune protection It has also been thought that the insertion of memory T- cells in a young/naive environment during tissue culture could restore some of the dying.